Anmeldung erfolgt in Kürze...
Details werden geladen...
Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia | The Manila Times
Webcast on Monday, June 29, 2026, at 7:45 am ET BALA CYNWYD, Pa., June 26, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host an investor event to discuss updates for the Company’s nomlabofusp clinical development program including a regulatory update and data from the ongoing long-term open label study for the treatment of Friedreich’s ataxia on Monday, June 29, 2026 at 7:45 am ET.
Ähnliche Seiten
Dianthus Therapeutics to Participate in Two Investor Conferences | The Manila Times
https://www.manilatimes.net/2026/05/27/tmt-newswire/globenewswire/dianthus-therapeutics-to-participate-in-two-investor-conferences/2352110Structure Therapeutics Announces Participation in Upcoming Investor Conferences | The Manila Times
https://www.manilatimes.net/2026/05/27/tmt-newswire/globenewswire/structure-therapeutics-announces-participation-in-upcoming-investor-conferences/2352124Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026 | The Manila Times
https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/design-therapeutics-to-host-investor-webcast-to-review-data-from-restore-fa-trial-of-dt-216p2-for-friedreichs-ataxia-on-monday-may-18-2026/2345763
Trevi Therapeutics Announces Upcoming June and July Event Schedule | The Manila Times
https://www.manilatimes.net/2026/06/17/tmt-newswire/globenewswire/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule/2367392Compass Therapeutics to Participate in Upcoming June Investor Events | The Manila Times
https://www.manilatimes.net/2026/05/28/tmt-newswire/globenewswire/compass-therapeutics-to-participate-in-upcoming-june-investor-events/2353550